Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

<< Previous

Bullboard Posts

Next >>

Post by aussyspitzon May 15, 2020 8:47am

155 Views

Post# 31032108

$50 to $100 by EOY Do you believe in the Tooth Fairy too?

Analyst Price Target on LMNL

$6.58 (6.58USD =9.27092CAD)

(-14.32% Downside)

Based on 1 analyst offering 12 month price targets for Liminal BioSciences in the last 3 months. The average price target is $6.58 with a high forecast of $6.58 and a low forecast of $6.58. The average price target represents a -14.32% decrease from the last price of $7.68.